This inventor holds 2 USPTO granted patents. Top assignees: Nektar Therapeutics, Novartis Ag. Active years: 2008-2013.
Company Filing History:
Years Active: 2008-2013
Title: Alan Kugler: Innovator in Amphotericin B Compositions
Introduction
Alan Kugler is a notable inventor based in Montara, California. He has made significant contributions to the field of pharmaceutical compositions, particularly those involving amphotericin B. With a total of 2 patents, his work focuses on innovative formulations and delivery systems that enhance the efficacy of this important compound.
Latest Patents
Kugler's latest patents include compositions comprising amphotericin B, methods, and systems for their application. One patent details compositions and formulations that incorporate amphotericin B along with one or more excipients. This invention outlines methods for creating these compositions and systems for their use. Another patent describes a composition that includes particles with at least 95 wt % of amphotericin B, where the particles have a mass median diameter ranging from about 1.1 µm to about 1.9 µm. Additionally, it specifies that at least 80 wt % of the particles have a geometric diameter within the same range. These innovations aim to improve the delivery and effectiveness of amphotericin B in pharmaceutical applications.
Career Highlights
Throughout his career, Alan Kugler has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Nektar Therapeutics. His experience in these organizations has contributed to his expertise in developing advanced pharmaceutical formulations.
Collaborations
Kugler has collaborated with notable colleagues such as Keith Washco and Theresa D. Sweeney. Their combined efforts have furthered research and development in the field of pharmaceutical sciences.
Conclusion
Alan Kugler's contributions to the field of amphotericin B compositions highlight his innovative spirit and dedication to improving pharmaceutical formulations. His patents and collaborations reflect a commitment to advancing medical science and enhancing patient care.